Showing results (241-250 of 520) with videos related to

Sort By:
Pageof 52
Clinical & Experimental Ophthalmology|May 5, 2020
Future burden of vision loss in Australia: Projections from the National Eye Health SurveyJoshua Foreman, Stuart Keel, Myra McGuiness, et al.
Heart Failure Reviews|July 29, 2016
The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practiceKen Lee Chin, Marina Skiba, Andrew Tonkin, et al.
Drugs - Real World Outcomes|June 9, 2024
Association of Drug-Disease Interactions with Mortality or Readmission in Hospitalised Middle-Aged and Older Adults: A Systematic Review and Meta-AnalysisJoshua M Inglis, Gillian Caughey, Tilenka Thynne, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Right Precordial T-Wave Inversion in Healthy Endurance Athletes Can Be Explained by Lateral Displacement of the Cardiac ApexMaria J Brosnan, Guido Claessen, Hein Heidbuchel, et al.
Drug Safety|December 30, 2006
Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003Steven J Haas, Richard Hill, Henry Krum, et al.
Circulation. Cardiovascular Quality and Outcomes|May 18, 2021
Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: A Health Economic AnalysisJennifer Zhou, Danny Liew, Stephen J Duffy, et al.
Clinical Therapeutics|February 23, 2010
The economic implications of treating atherothrombotic disease in Australia, from the government perspectiveZanfina Ademi, Danny Liew, Bruce Hollingsworth, et al.
Diabetes Care|October 22, 2021
The Impact of Diabetes on Productivity in IndiaKhyati K Banker, Danny Liew, Zanfina Ademi, et al.
Journal of the American Heart Association|February 6, 2020
Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid-Lowering Medication: A Cohort StudyMaarit J Korhonen, Jaana Pentti, Juha Hartikainen, et al.
European Journal of Preventive Cardiology|March 20, 2025
Rethinking Cardiovascular Prevention: Cost-Effective Cholesterol Lowering for Statin-Intolerant Patients in Australia and the UKJedidiah I Morton, Danny Liew, Gerald F Watts, et al.
Pageof 52